Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Corbus Pharmaceuticals Holdings, Inc. - Common Stock
(NQ:
CRBP
)
6.030
+0.110 (+1.86%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 17, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Corbus Pharmaceuticals Holdings, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Marijuana Stock Movers For April 18, 2025
April 18, 2025
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Movers For April 17, 2025
April 17, 2025
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Gainers And Losers From April 16, 2025
April 16, 2025
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Bearish Tuesday For Marijuana Stocks - Rocky Mountain High, Cara Therapeutics Among Top Gainers
April 15, 2025
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Gainers And Losers From April 11, 2025
April 11, 2025
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Gainers And Losers From April 8, 2025
April 08, 2025
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Movers For April 2, 2025
April 02, 2025
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Bullish Sentiment Across The Cannabis Space - Check Full Movers For April 1, 2025
April 01, 2025
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Movers For March 28, 2025
March 28, 2025
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Marijuana Stock Movers For March 24, 2025
March 24, 2025
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Movers For March 18, 2025
March 18, 2025
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Movers For February 17, 2025
February 17, 2025
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Corbus Pharmaceuticals Highlights Data From Its First US-Based Trial Of Lead Cancer Drug Candidate
February 14, 2025
Corbus Pharmaceuticals presented Phase 1 data on CRB-701 at ASCO GU, showing safety, tolerability, and responses across multiple tumor types.
Via
Benzinga
Bearish Sentiment Across The Cannabis Space - Check Full Movers For January 20, 2025
January 20, 2025
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Marijuana Stock Movers For October 23, 2024
October 23, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Movers For October 21, 2024
October 21, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Marijuana Stock Movers For October 21, 2024
October 21, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Gainers And Losers From October 9, 2024
October 09, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Bullish Sentiment Across The Cannabis Space - Check Full Movers For October 8, 2024
October 08, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Gainers And Losers From October 4, 2024
October 04, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
As Weight-Loss Drugs Battle, Upstart Viking Therapeutics Threatens Eli Lilly, Novo Nordisk, Pfizer
October 04, 2024
Viking Therapeutics is an upstart in the weight-loss drugs space. But it's catching attention.
Via
Investor's Business Daily
Cannabis Stock Movers For October 2, 2024
October 02, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Gainers And Losers From October 1, 2024
October 01, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Cannabis Stock Movers For September 25, 2024
September 25, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
12 Health Care Stocks Moving In Wednesday's Intraday Session
September 25, 2024
Via
Benzinga
Nasdaq-Traded Cannabinoid Biotech Corbus Pharma Stock Plunges 60%, But Analysts Say 'Buy The Dip' Now
September 23, 2024
Corbus Pharmaceuticals received buy ratings from H.C. Wainwright and Oppenheimer, citing the company's diversified pipeline.
Via
Benzinga
Cannabis Stock Movers For September 20, 2024
September 20, 2024
Via
Benzinga
Topics
Cannabis
Exposures
Cannabis
Novo Nordisk's Monlunabant Data Drags Stocks Of Smaller Players
September 20, 2024
Novo Nordisk announced positive Phase 2a trial results for monlunabant, showing significant weight loss with a 10 mg dose. However, investors reacted to limited gains at higher doses. Corbus...
Via
Benzinga
Crude Oil Moves Higher; Sable Offshore Shares Slide
September 20, 2024
Via
Benzinga
Exposures
Fossil Fuels
Gold Gains Over 1%; Battalion Oil Shares Spike Higher
September 20, 2024
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.